Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain (Q81060793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1 reference

15

Hans-Jürgen Möller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Harald Hampel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Andreas Haslinger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Michael Scheloske

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Frank Padberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Petra Fischer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Josef Unger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Stefan Johannes Teipel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Michaela Neumann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Carlyn Rosenberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Rusti Oshida

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Christine Hulette

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Dieter Pongratz

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Michael Ewers

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

H A Kretzschmar

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

26 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

European Archives of Psychiatry and Clinical Neuroscience

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

269-278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15565298%20AND%20SRC:MED&resulttype=core&format=json

Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid

5 January 2020

cites work

1 reference

12 December 2020

Impaired neuroglial activation in interleukin-6 deficient mice

1 reference

12 December 2020

Molecular basis underlying functional pleiotropy of cytokines and growth factors

1 reference

12 December 2020

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

12 December 2020

Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130

1 reference

12 December 2020

In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex

1 reference

12 December 2020

Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system

1 reference

12 December 2020

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

1 reference

12 December 2020

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

12 December 2020

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

12 December 2020

Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production

1 reference

12 December 2020

Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients

1 reference

12 December 2020

Polymorphisms of the interleukin-6 gene are associated with bone mineral density

1 reference

12 December 2020

Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling

1 reference

12 December 2020

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

12 December 2020

Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism

1 reference

12 December 2020

Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid

1 reference

12 December 2020

Gp130 and the interleukin-6 family of cytokines

1 reference

12 December 2020

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

1 reference

12 December 2020

Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

1 reference

12 December 2020

The expression of cytokines and their receptors in normal and mildly reactive human brain

1 reference

12 December 2020

1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling

1 reference

12 December 2020

Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients

1 reference

12 December 2020

No association between anti-myelin oligodendrocyte glycoprotein antibodies and serum/cerebrospinal fluid levels of the soluble interleukin-6 receptor complex in multiple sclerosis

1 reference

12 December 2020

Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats

1 reference

12 December 2020

Physiological and pathological roles of interleukin-6 in the central nervous system

1 reference

12 December 2020

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

12 December 2020

The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site

1 reference

12 December 2020

Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins

1 reference

12 December 2020

Sympathetic neurons can produce and respond to interleukin 6

1 reference

12 December 2020

Interleukin-6 and its receptor: a paradigm for cytokines

1 reference

12 December 2020

Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes

1 reference

12 December 2020

Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system

1 reference

12 December 2020

High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130

1 reference

12 December 2020

Solution structure of recombinant human interleukin-6

1 reference

12 December 2020

Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells

1 reference

12 December 2020

TNF alpha induces IL-6 production by astrocytes but not by microglia

1 reference

12 December 2020

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

12 December 2020

Interleukin-6 and interleukin-6 receptor mRNA expression in rat central nervous system

1 reference

12 December 2020

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

1 reference

12 December 2020

Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients

1 reference

12 December 2020

Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease

1 reference

12 December 2020

Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family

1 reference

12 December 2020

Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6

1 reference

12 December 2020

Molecular cloning and expression of an IL-6 signal transducer, gp130

1 reference

12 December 2020

Interleukin-6: an overview

1 reference

12 December 2020

The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes

1 reference

12 December 2020

IL-6 cytokine family and signal transduction: a model of the cytokine system

1 reference

12 December 2020

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

12 December 2020

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

1 reference

12 December 2020

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

1 reference

12 December 2020

Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

1 reference

12 December 2020

On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

1 reference

12 December 2020

IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage.

1 reference

12 December 2020

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease

1 reference

12 December 2020

Biological and clinical aspects of interleukin 6.

1 reference

12 December 2020

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

12 December 2020

Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience.

1 reference

12 December 2020

Interleukin-6 and the acute phase response

1 reference

12 December 2020

CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.

1 reference

12 December 2020

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease

1 reference

12 December 2020

Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

12 December 2020

Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

1 reference

12 December 2020

Inflammatory mechanisms in Alzheimer's disease

1 reference

12 December 2020

Signaling mechanisms through gp130: a model of the cytokine system

1 reference

12 December 2020

Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.

1 reference

12 December 2020

Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha).

1 reference

12 December 2020

Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats

1 reference

12 December 2020

Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.

1 reference

12 December 2020

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

1 reference

12 December 2020

Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor.

1 reference

12 December 2020